Neurodegeneration in Cognitive Impairment and Mood Disorders for Experimental, Clinical and Translational Neuropsychiatry
Open accessThe DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.
Abstract
Neurodegeneration poses a significant challenge for the fields of neuroscience and medicine, as it is the underlying cause of the development and advancement of numerous neurodegenerative and psychiatric disorders [...]
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Biomarkers for neurodegenerative diseases
Hansson, O. (2021) · Nature Medicine · doi:10.1038/s41591-021-01382-x · Cited by 1,159
The neuropsychology of mood disorders
Chamberlain, S. R., & Sahakian, B. J. (2006) · Current Psychiatry Reports · doi:10.1007/s11920-006-0051-x · Cited by 140
De Silva, M. J., Cooper, S., Li, H. L., Lund, C., & Patel, V. (2013) · British Journal of Psychiatry · doi:10.1192/bjp.bp.112.118018 · Cited by 125
Lysaker, P. H., Vohs, J., Hillis, J. D., Kukla, M., Popolo, R., Salvatore, G., & Dimaggio, G. (2013) · Expert Review of Neurotherapeutics · doi:10.1586/14737175.2013.811150 · Cited by 124
Evidence-Based Psychotherapy for Schizophrenia
Dickerson, F. B., & Lehman, A. F. (2011) · Journal of Nervous & Mental Disease · doi:10.1097/nmd.0b013e318225ee78 · Cited by 63 · cited 1×
“Treatment for this condition generally involves the use of antipsychotic medication, as well as psychotherapy and psychosocial interventions [68–70].”
BackgroundHussain, M., Kumar, P., Khan, S., Gordon, D. K., & Khan, S. (2020) · Cureus · doi:10.7759/cureus.11613 · Cited by 49
Arnold, C., Farhall, J., Villagonzalo, K.-A., Sharma, K., & Thomas, N. (2021) · Internet Interventions · doi:10.1016/j.invent.2021.100411 · Cited by 34 · cited 1×
“Nevertheless, the outcomes of these treatments can vary depending on several factors [71–73].”
Background
Cited by
Parkinson’s Disease: Bridging Gaps, Building Biomarkers, and Reimagining Clinical Translation
Tanaka, M. (2025) · doi:10.20944/preprints202506.2099.v2 · Cited by 57
Self-citationTanaka, M. (2025) · doi:10.20944/preprints202412.0679.v2 · Cited by 42
Self-citationQuinoline Quest: Kynurenic Acid Strategies for Next-Generation Therapeutics via Rational Drug Design
Tanaka, M., Szatmári, I., & Vécsei, L. (2025) · doi:10.20944/preprints202503.2399.v1 · Cited by 30
Self-citationTanaka, M. (2024) · Advances in Clinical and Experimental Medicine · doi:10.17219/acem/197425 · Cited by 27
Self-citationTanaka, M., Battaglia, S., & Liloia, D. (2025) · Biomedicines · doi:10.3390/biomedicines13051045 · Cited by 24
Self-citation
Metadata
- Authors
- Battaglia, S., Avenanti, A., Vécsei, L., & Tanaka, M.
- Venue
- Biomedicines
- Publisher
- MDPI AG
- Published
- 2024-03-05
- Volume
- 12
- Issue
- 3
- Pages
- 574
- ISSN
- 2227-9059 (ISSN-L)
- OpenAlex
- W4392471062
- Cited by
- 45
- References
- 7
- FWCI
- 12.11
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Neurodegeneration in Cognitive Impairment and Mood Disorders for Experimental, Clinical and Translational Neuropsychiatry. https://app.cochat.ai/papers/10.3390/biomedicines12030574
- The paper
- Battaglia, S., Avenanti, A., Vécsei, L., & Tanaka, M. (2024). Neurodegeneration in Cognitive Impairment and Mood Disorders for Experimental, Clinical and Translational Neuropsychiatry. Biomedicines. https://doi.org/10.3390/biomedicines12030574
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.